Perspectives in the Diagnosis, Clinical Impact, and Management of the Vulnerable Plaque

Area of Science:

• Cardiology
• Vascular Biology
• Medical Imaging

Background:

• Coronary artery disease (CAD) is a leading global cause of mortality.
• Acute coronary syndromes (ACS) result from thrombus formation in coronary arteries, causing reduced blood flow and myocardial perfusion.
• Vulnerable plaques, characterized by specific features like thin fibrous caps and lipid pools, increase coronary event risk even without flow limitation.

Purpose of the Study:

• To review the current understanding of vulnerable coronary plaques.
• To summarize pharmacological management strategies for vulnerable plaques.
• To provide an updated overview of preventive percutaneous coronary interventions (PCI) for vulnerable plaques.

Main Methods:

• Review of current literature on vulnerable plaques.
• Analysis of advancements in intravascular imaging and coronary computed tomography (CCT).
• Synthesis of evidence regarding pharmacological and interventional strategies.

Main Results:

• Intravascular imaging and CCT have improved the detection and characterization of vulnerable plaques.
• The clinical impact of identifying vulnerable plaques on patient outcomes is supported by multiple studies.
• Pharmacological and interventional strategies aim to stabilize plaques and prevent adverse events.

Conclusions:

• Vulnerable plaque identification is crucial for risk stratification in coronary artery disease.
• Management involves a combination of medical therapy and potentially preventive percutaneous interventions.
• Further research and clinical application of advanced imaging are essential for optimizing patient care.